Single source provider of full-service therapeutic antibody development

ImmunoPrecise offers a comprehensive suite of solutions to rapidly deliver high-performing therapeutic antibodies. The company works on royalty-free contract research agreements and partnership models.

Like Comment
Page of
Go to the profile of ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies, Ltd (IPA) is an industry leading, CRO, providing single-source therapeutic antibody discovery services featuring B cell Select, Phage Display, and Hybridoma platforms. IPA an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ single-cell technology and the DeepDisplay™ custom phage libraries, as well as the Abthena™ bispecific program. All of these technologies integrate seamlessly with IPA’s integrated Artemis™ Intelligence Metadata (AIM)™ capabilities to enable rapid turnaround on additional outputs in therapeutic optimization, stability, affinity, and manufacturability.

No comments yet.